forty four Additionally, anergic cells Ordinarily retain the next susceptibility to apoptosis Unless of course anti-apoptotic proteins which include BCL2 are overexpressed, as is the case for CLL cells.45 Certainly, most significant therapeutic innovations developing in the final 10 years are related to the inhibition of BCR and BCL2-mediated signa